Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Sonnet BioTherapeutics Files 10-K

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001106838/000149315221031781/form10-k.htm

byBenzinga Newsdesk

December 17, 2021

1 minute read

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001106838/000149315221031781/form10-k.htm

Morgan Stanley Maintains Equal-Weight on Spire, Lowers Price Target to $79

By Benzinga Newsdesk

July 20, 10:32 AM

Morgan Stanley analyst Stephen Byrd maintains Spire (NYSE:SR) with a Equal-Weight and lowers the price target from $84 to $79.

News

The U.S. Economy Faces Elevated Risks Of A Recession Over The Next One To Two Years

By Benzinga Newsdesk

June 22, 8:27 AM

-Wall Street Journal

SPY

Verizon Vs. AT&T: How These High Yielders Stack Up On Dividends

By Robert Kuczmarski

October 23, 4:27 PM

As we enter the third-quarter earnings season, many investors will be analyzing stocks for future trades.

AXP

‘Time To Get Richer Is Coming:’ Rich Dad Poor Dad Author Says He Would Buy Bitcoin At This Level

By Madhukumar Warrier

January 25, 1:34 AM

Robert Kiyosaki — the author of the best-selling financial education book “Rich Dad Poor Dad”— said that the crash in Bitcoin’s (CRYPTO: BTC) price is “great news” and the time t

BTC

Sonnet BioTherapeutics Files 10-K

Related Posts

Morgan Stanley Maintains Equal-Weight on Spire, Lowers Price Target to $79

The U.S. Economy Faces Elevated Risks Of A Recession Over The Next One To Two Years

Verizon Vs. AT&T: How These High Yielders Stack Up On Dividends

‘Time To Get Richer Is Coming:’ Rich Dad Poor Dad Author Says He Would Buy Bitcoin At This Level